CDTX vs PODD · rev $1.3M vs P/E 34, rev $2.07B
Cidara Therapeutics Inc (CDTX) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
CDTX currently screens at market cap $6.96B. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the CDTX and PODD stock pages for the full models.
Not investment advice.